Thymosin Beta-4 Is a Key Exercise-Released Peptide That Acts as a Growth Factor

Thymosin beta-4 was identified as the most upregulated exercise-released peptide from contracting muscle, with levels also acutely increased in exercising humans regardless of insulin resistance status.

Gonzalez-Franquesa, Alba et al.·American journal of physiology. Cell physiology·2021·ModerateMixed Methods (Proteomics, Human Observational, Animal, In Vitro)
RPEP-05412Mixed Methods (Proteomics, Human Observational, Animal, In Vitro)Moderate2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Mixed Methods (Proteomics, Human Observational, Animal, In Vitro)
Evidence
Moderate
Sample
N=Multiple components (human exercise subjects + mouse + cell culture)
Participants
Exercising humans (with and without insulin resistance), C2C12 myotubes, obese mice, osteoblasts, neurons

What This Study Found

TMSB4X was the most upregulated secreted protein from contracting C2C12 myotubes by MS-based proteomics, and was acutely increased in plasma of exercising humans irrespective of insulin resistance status.

Key Numbers

Most upregulated secreted protein; acutely elevated in human plasma; increased osteoblast proliferation; promoted neurite outgrowth; no metabolic benefit in obese mice

How They Did This

Proteomics study. MS-based secretome analysis of contracting C2C12 myotubes in vitro. Human plasma TMSB4X levels measured during exercise in subjects with and without insulin resistance.

Why This Research Matters

Identifying thymosin beta-4 as a major exerkine could explain how exercise promotes tissue repair, cardiovascular health, and brain protection. It opens the possibility of using TMSB4X therapeutically as an "exercise mimetic" for people who cannot exercise.

The Bigger Picture

Thymosin beta-4 is already known for wound healing and tissue repair. Identifying it as a major exercise-released factor connects these regenerative properties to the systemic benefits of physical activity, potentially explaining exercise's protective effects across multiple organ systems.

What This Study Doesn't Tell Us

Initial discovery from in vitro muscle cell model. Human plasma measurements were acute (exercise session), not chronic. Functional significance of exercise-induced TMSB4X increase needs further investigation. Dose-response and tissue-specific effects unknown.

Questions This Raises

  • ?Could thymosin beta-4 supplementation replicate some benefits of exercise for sedentary or immobile individuals?
  • ?Which organs and tissues are most responsive to exercise-released thymosin beta-4?
  • ?Does chronic exercise training increase baseline thymosin beta-4 levels?

Trust & Context

Key Stat:
Most upregulated exerkine Thymosin beta-4 was the single most upregulated secreted protein from contracting muscle cells, positioning it as a key mediator of exercise benefits
Evidence Grade:
Moderate evidence: combines in vitro proteomics discovery with human exercise validation. Functional significance needs further study.
Study Age:
Published 2021. The exerkine field is rapidly growing with increasing interest in exercise-released peptides.
Original Title:
Discovery of thymosin β4 as a human exerkine and growth factor.
Published In:
American journal of physiology. Cell physiology, 321(5), C770-C778 (2021)
Database ID:
RPEP-05412

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is an exerkine?

Exerkines are signaling molecules released by muscles and other organs during exercise. They travel through the blood to communicate with distant organs, helping explain how exercise benefits the heart, brain, immune system, and other tissues beyond just the muscles being used.

Could thymosin beta-4 supplements replace exercise?

Not likely as a complete replacement, since exercise involves many pathways. However, identifying TB4 as a major exerkine suggests it mediates some exercise benefits, which could be therapeutically relevant for people who cannot exercise due to illness, injury, or disability.

Read More on RethinkPeptides

Cite This Study

RPEP-05412·https://rethinkpeptides.com/research/RPEP-05412

APA

Gonzalez-Franquesa, Alba; Stocks, Ben; Borg, Melissa L; Kuefner, Michael; Dalbram, Emilie; Nielsen, Thomas S; Agrawal, Ankita; Pankratova, Stanislava; Chibalin, Alexander V; Karlsson, Håkan K R; Gheibi, Sevda; Björnholm, Marie; Jørgensen, Niklas Rye; Clemmensen, Christoffer; Hostrup, Morten; Treebak, Jonas T; Krook, Anna; Zierath, Juleen R; Deshmukh, Atul S. (2021). Discovery of thymosin β4 as a human exerkine and growth factor.. American journal of physiology. Cell physiology, 321(5), C770-C778. https://doi.org/10.1152/ajpcell.00263.2021

MLA

Gonzalez-Franquesa, Alba, et al. "Discovery of thymosin β4 as a human exerkine and growth factor.." American journal of physiology. Cell physiology, 2021. https://doi.org/10.1152/ajpcell.00263.2021

RethinkPeptides

RethinkPeptides Research Database. "Discovery of thymosin β4 as a human exerkine and growth fact..." RPEP-05412. Retrieved from https://rethinkpeptides.com/research/gonzalez-franquesa-2021-discovery-of-thymosin-4

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.